# The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma

> **NCT05645484** · — · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 100 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** 18F-PFPN
- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT05645484
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-02
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645484, "The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05645484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*